Preclinical Gold Complexes as Oral Drug Candidates to Treat Leishmaniasis Are Potent Trypanothione Reductase Inhibitors-Reference-Cited by-同舟云学术

Preclinical Gold Complexes as Oral Drug Candidates to Treat Leishmaniasis Are Potent Trypanothione Reductase Inhibitors

Published:2020-04-13 Issue:5 Volume:6 Page:1121-1139
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Tunes Luiza G.¹,Morato Roberta E.¹,Garcia Adriana²,Schmitz Vinicius²,Steindel Mario³,Corrêa-Junior José D.⁴,Dos Santos Hélio F.²^ORCID,Frézard Frédéric⁵,de Almeida Mauro V.²,Silva Heveline⁶^ORCID,Moretti Nilmar S.⁷,de Barros André L. B.⁸,do Monte-Neto Rubens L.¹^ORCID

Affiliation:

1. Instituto René Rachou/Fiocruz Minas−Fundação Oswaldo Cruz, Belo Horizonte 30190-009, Brasil

2. Departamento de Química, Instituto de Ciências Exatas, Universidade Federal de Juiz de Fora, Juiz de Fora 36036-900, Brasil

3. Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de Santa Catarina, Florianópolis 88040-900, Brasil

4. Departamento de Morfologia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brasil

5. Departamento de Fisiologia e Biofísica, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brasil

6. Departamento de Química, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brasil

7. Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo, São Paulo 04023-062, Brasil

8. Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brasil

Funder

Funda??o de Amparo ? Pesquisa do Estado de Minas Gerais

Instituto Serrapilheira

Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico

Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo

International Society for Infectious Diseases

Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

http://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.9b00505

Reference93 articles.

1. Mucosal leishmaniasis

2. Immunopathogenic competences ofLeishmania(V.)braziliensisandL.(L.)amazonensisin American cutaneous leishmaniasis

3. Chemotherapy of leishmaniasis: present challenges

4. Leishmaniasis and various immunotherapeutic approaches

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Metal Complexes Based on Biomimetic and Biocompatible Organic Ligands against Leishmaniasis Infections: State of the Art and Alternatives;Inorganics;2024-07-12

2. Design, synthesis, and biological evaluation of eugenol-isoxazoline hybrid derivatives as potential anti-leishmanial agents;Journal of Molecular Structure;2024-07

3. Exploring Leishmaniasis: Contemporary modalities, potentiality of plant chemicals and green synthesized nanotherapeutics as effective leishmanicidal drugs;Annals of Phytomedicine An International Journal;2024-07

4. Compounds with potentialities as novel chemotherapeutic agents in leishmaniasis at preclinical level;Experimental Parasitology;2024-05

5. Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents;Pharmaceutics;2024-03-25